2 March 2023
SHARE NOW
ATW
Cell Therapy
Clinical Trials
Collaborations, Mergers & Acquisitions
Gene Therapy
Partnering
Scaling Up
Strategy
This Briefing from Advanced Therapies Week 2023 focusses on how partnerships within the industry can advance research from the clinic to manufacturing scale, to keep pace with the evolving field.
During this session, Terumo’s Stuart Gibb, PhD, Scientific Strategy Lead at Terumo Blood and Cell Technologies, is joined by Nisha C. Durand, PhD, Principal Research Technologist at Mayo Clinic and Matthew M. Hewitt, B.A. PhD, Executive Director, Scientific Services Cell and Gene Therapy at Charles River.
This Briefing was presented at Advanced Therapies Week 2023, in partnership with Terumo.
More like this
20 Years of Advanced Therapies with David McCall: a Retrospective on Phacilitate’s Founding and Evolution of the Industry
Lee Buckler, SVP Advanced Therapies, Blood Centers of America, Advanced Therapies Network, reflects on two decades of working within the advanced therapies industry as Phacilitate celebrates 20 years of operating in the field.
4 December 2023
Oxford Biomedica Acquires ABL Europe from Institut Mérieux
Oxford Biomedica Acquires ABL Europe from Institut Mérieux
6 December 2023
Texas Children’s Hospital First to Deliver a Novel Gene Therapy for Rett Syndrome
Two female pediatric patients with Rett syndrome were the first children worldwide to receive the promising treatment with Neurogene’s lead gene therapy product.
5 December 2023
Discover more like this
